PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Etoricoxib manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

etoricoxib + thiocolchicoside

Tablets 60 mg + 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18268
A formulation-focused pharmaceutical manufacturer with multiple facilities dedicated to oral solid dosage forms and hormone therapies, offering a broad portfolio of pharmaceutical products in areas such as women’s health, cardio-metabolic care, pain management and urology. The company runs several advanced production lines capable of handling complex drug-delivery systems, and operates manufacturing sites that are certified to EU-GMP and WHO-GMP standards, supporting process excellence and reliable large-scale supply of pharmaceutical products for domestic and international partners.

Manufacturer usually replies in 10 days

etoricoxib

Tablets 30 mg, 60 mg, 90 mg, 120 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Peru
Registered in
Germany , Spain , United Kingdom
Available for
Licensing with supply, Distribution only
MAs available in
Spain , United Kingdom
Comments
MAs available: UK, ES Dossier availability: Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 36 days

etoricoxib

Tablets 30 mg, 60 mg, 90 mg, 120 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Arcoxia® Tablets (Merck & Co)
Manufacturer #18226
The company has a strong global presence, partnering with over 100 pharmaceutical companies and distributors across 28 countries, including regions such as North America, Europe, Latin America, Southeast Asia, CIS, Russia, the Middle East, and Africa. It operates 10 manufacturing facilities with approvals from major regulatory bodies, including the US FDA, UK MHRA, Korea KFDA, Ukraine GMP, and others, ensuring compliance with international standards. With a focus on research and development, manufacturing, and business development, the company leverages over 30 years of experience in oral solid dosage forms to expand rapidly into nutraceuticals and injectables, maintaining a robust and versatile product portfolio.

Manufacturer usually replies in 21 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Etoricoxib drug?

Etoricoxib is a selective COX-2 inhibitor. Etoricoxib is used to treat rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain, and gout. Etoricoxib helps to reduce the pain and inflammation in the joints and muscles of people. McOLSON Research Laboratories developed Etoricoxib; it was patented in 1996 and approved for medical use in 2002. Etoricoxib is a globally found drug; it is in use in more than eighty countries. However, in the US, the FDA has required some more safety and efficacy data for etoricoxib before it will issue approval. The etoricoxib approval indications can change by country. In the UK, Etoricoxib is authorized for the short term treatment of moderate pain after dental surgery of adults.

Etoricoxib manufacturers and wholesalers:

Etoricoxib has many brand names; the most known is Gencox. Some of the others are Algix and Tauxib in Italy, Arcox, Berrica, and Starcox in Pakistan, Arcoxia in Spain, Egypt, Saudi Arabia, Sweden, Finland, Norway, Estonia, Germany, Greece, Lithuania, Luxembourg, Chile, China, Hong Kong, Hungary, Indonesia, Ireland, Israel, and more. Torrent Pharma (UK) Ltd is the Marketing Authorisation Holder and Manufacturer. Etoricoxib suppliers market it in the form of film-coated tablets of 30 mg, 60 mg, 90 mg, and 120 mg.

Etoricoxib for sales:

Etoricoxib prices can change depending on the country. In Canada for a 90 mg film-coated tablet, Etoricoxib costs from $0.69 to $0.77 per unit. In France, for a 60 me film-coated tablet, Etoricoxib costs about 0.31€ per unit, and in the UK, for a 30 mg film-coated tablet, Etoricoxib costs about £0.47.
As Etoricoxib is a globally found drug, you may encounter fraudulent online websites that will want to sell Etoricoxib with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid time-consuming sourcing, and you directly find qualified sellers of Etoricoxib. Those manufacturers have been through quality control procedures to assure the Etoricoxib distributors they were qualified partners. On the online platform, Etoricoxib is mostly available from the EU, India, Israel, Canada, and Argentina. Thanks to the intuitive online marketplace, you will find Etoricoxib and many other drugs quickly and efficiently. Placing an order or an inquiry has never been easier than with Pipelinepharma. Let us connect you with Etoricoxib manufacturers from wherever in the world.

How to use Etoricoxib drugs?

To treat osteoarthritis with Etoricoxib, the recommended dose for an adult patient is 30 mg once a day; it can be increased to a maximum of 60 mg once a day if needed. To treat Rheumatoid arthritis and Ankylosing spondylitis, an adult patient should take 60 mg once a day, increased to a maximum of 90 mg once a day if needed.
Following an Etoricoxib treatment can cause some side effects. The most common ones include stomach pain, dry socket, swelling of the legs and, or feet due to fluid retention, dizziness, headache, palpitations, irregular heart rhythm (arrhythmia), increased blood pressure.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.